DE69719640T2 - Amorphe Benzothiophen, Verfahren zur Herstellung und Verwendung - Google Patents

Amorphe Benzothiophen, Verfahren zur Herstellung und Verwendung

Info

Publication number
DE69719640T2
DE69719640T2 DE69719640T DE69719640T DE69719640T2 DE 69719640 T2 DE69719640 T2 DE 69719640T2 DE 69719640 T DE69719640 T DE 69719640T DE 69719640 T DE69719640 T DE 69719640T DE 69719640 T2 DE69719640 T2 DE 69719640T2
Authority
DE
Germany
Prior art keywords
benzothiophene
amorphous
manufacture
amorphous benzothiophene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69719640T
Other languages
English (en)
Other versions
DE69719640D1 (de
Inventor
George William Cuff
Arvind Lavji Thakkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69719640D1 publication Critical patent/DE69719640D1/de
Application granted granted Critical
Publication of DE69719640T2 publication Critical patent/DE69719640T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DE69719640T 1996-08-28 1997-08-22 Amorphe Benzothiophen, Verfahren zur Herstellung und Verwendung Expired - Fee Related DE69719640T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2483196P 1996-08-28 1996-08-28

Publications (2)

Publication Number Publication Date
DE69719640D1 DE69719640D1 (de) 2003-04-17
DE69719640T2 true DE69719640T2 (de) 2003-11-06

Family

ID=21822611

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69719640T Expired - Fee Related DE69719640T2 (de) 1996-08-28 1997-08-22 Amorphe Benzothiophen, Verfahren zur Herstellung und Verwendung

Country Status (25)

Country Link
EP (1) EP0826682B1 (de)
JP (1) JP2002514174A (de)
KR (1) KR20000035941A (de)
CN (1) CN1244124A (de)
AR (2) AR009333A1 (de)
AT (1) ATE234295T1 (de)
AU (1) AU723987B2 (de)
BR (1) BR9713176A (de)
CA (1) CA2263175A1 (de)
CO (1) CO4650039A1 (de)
CZ (1) CZ64399A3 (de)
DE (1) DE69719640T2 (de)
EA (1) EA002022B1 (de)
ES (1) ES2195089T3 (de)
HU (1) HUP0001172A3 (de)
IL (1) IL128641A (de)
IN (1) IN182940B (de)
NO (1) NO990914L (de)
NZ (1) NZ333839A (de)
PE (1) PE108598A1 (de)
PL (1) PL333356A1 (de)
TR (1) TR199900403T2 (de)
WO (1) WO1998008513A1 (de)
YU (1) YU10599A (de)
ZA (1) ZA977617B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980033284A (ko) * 1996-10-30 1998-07-25 피터지.스트링거 개선된 유방암 예방법
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
EP1832583A1 (de) * 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Neue Schwefelsäureadditionssalze aus Raloxifen und/oder Solvate daraus sowie pharmazeutische Zusammensetzungen damit
US20050008704A1 (en) * 2003-07-11 2005-01-13 Ray Anup Kumar Pharmaceutical composition for solubility enhancement of hydrophobic drugs
JPWO2007072869A1 (ja) * 2005-12-21 2009-06-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 １，２−ジヒドロピリジン化合物の非晶質体
WO2008047105A1 (en) 2006-10-17 2008-04-24 Cipla Limited Crystalline form of benzothiophene compound and process for preparation thereof
EP2448562B1 (de) 2009-07-02 2013-11-06 Synthon B.V. Raloxifen-zusammensetzung
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
ITMI20121821A1 (it) * 2012-10-25 2014-04-26 Erregierre Spa Composizione farmaceutica solubile in acqua a base di un sale di raloxifene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230862A (en) * 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5631369A (en) * 1994-08-31 1997-05-20 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
HUP0001172A3 (en) 2002-01-28
DE69719640D1 (de) 2003-04-17
TR199900403T2 (xx) 2002-01-21
YU10599A (sh) 2001-07-10
AR009333A1 (es) 2000-04-12
NZ333839A (en) 2001-06-29
PE108598A1 (es) 1999-01-13
IL128641A0 (en) 2000-01-31
EP0826682A1 (de) 1998-03-04
IL128641A (en) 2001-10-31
CO4650039A1 (es) 1998-09-03
NO990914D0 (no) 1999-02-25
KR20000035941A (ko) 2000-06-26
ZA977617B (en) 1999-02-25
CZ64399A3 (cs) 1999-05-12
BR9713176A (pt) 2000-02-08
HUP0001172A2 (hu) 2001-06-28
EA002022B1 (ru) 2001-12-24
EA199900235A1 (ru) 1999-08-26
ATE234295T1 (de) 2003-03-15
PL333356A1 (en) 1999-12-06
CN1244124A (zh) 2000-02-09
EP0826682B1 (de) 2003-03-12
AU723987B2 (en) 2000-09-07
WO1998008513A1 (en) 1998-03-05
IN182940B (de) 1999-08-14
NO990914L (no) 1999-02-25
AR009334A1 (es) 2000-04-12
ES2195089T3 (es) 2003-12-01
CA2263175A1 (en) 1998-03-05
AU4233597A (en) 1998-03-19
JP2002514174A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
DE69726788D1 (de) Aluminiumhydroxid, Verfahren zur Herstellung und Verwendung davon
DE69921099D1 (de) Wärmeausdehnbare mikrokapseln, verfahren zur herstellung und verwendung derselben
DE69703048D1 (de) Glaszusammensetzung, verfahren und verwendung
DE59910809D1 (de) Stickoxid-Speichermaterial und daraus hergestellter Stickoxid-Speicherkatalysator, Verfahren zu dessen Herstellung und seine Verwendung
DE69508022D1 (de) Hydrobehandlungskatalysator, seine Herstellung und Verwendung
DE69933214D1 (de) Verfahren zur herstellung von waschbaren, trocknenden und elastischen gegenständen
DE59707078D1 (de) Monoolefinische c 5-mononitrile, verfahren zu ihrer herstellung und ihrer verwendung
DE19880237D2 (de) Deformationselement, Verfahren zu seiner Herstellung und seine Verwendung
DE69511248D1 (de) Polycarbomate, verfahren zur herstellung von polycarbomaten und verfahren zur herstellung von polyisocyanaten
DE69708428T2 (de) Zwischenprodukte und Verfahren zur Herstellung Olanzapin
DE59401015D1 (de) Hydrierkatalysator, ein Verfahren zur Herstellung und Verwendung
DE69719640T2 (de) Amorphe Benzothiophen, Verfahren zur Herstellung und Verwendung
DE69622051D1 (de) Verfahren zur herstellung von 2,4-dihydroxy-pyridin und 2,4-dihydroxy-3-nitropyridin
DE69531132D1 (de) Blattförmiger Sauerstoff-Absorber und Verfahren zur Herstellung
DE69413183D1 (de) Indazolsulfonylharnstoff-derivat, verwendung und zwischenprodukte zur herstellung
DE59810658D1 (de) Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung desselben
ATE329947T1 (de) Polyolefinzusammensetzung, verfahren zur herstellung und die verwendung davon
DE69406655D1 (de) Amorphes Aluminosilikat und Verfahren zu seiner Herstellung
DE59506861D1 (de) Schwefelorganische Goldverbindungen, Verfahren zu ihrer Herstellung und Verwendung derselben
ATE217620T1 (de) Verfahren zur herstellung von benzothiophenen
DE59706605D1 (de) Hotmelt-Transfermaterial, Verfahren zu seiner Herstellung und dessen Verwendung
DE19780393D2 (de) Abgabeeinheit, Verfahren zur ihrer Herstellung und ihre Verwendung
DE69517921D1 (de) Neues, amorphes Komplexmakromolekül und seine Verwendung
DE69722411D1 (de) Katalytische zusammensetzung, deren herstellung, und deren verwendung zur katalytischen verbrennung
DE69609282T2 (de) Succinamid-Derivat, Verfahren zur Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee